Chronic myeloid leukaemia: open trials in South Korea

11 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-04
NCT06163430
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
Trial Treatment · Phase 1/2 · Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Hallym University Sacred Heart Hospital, Anyang-si · Dong-A University Hospital, Busan · Keimyung University Dongsan Hospital, Daegu · Uijeorigbu Eulji Medical Center, Eulji University, Uijeongbu-si
Registry updated 2026-10-15
NCT07354074
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-10-15
NCT04925479
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Seoul
Registry updated 2026-09-25
NCT06423911
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Busan · Busan · Gyeonggi-do · Seoul · Seoul · Seoul · Seoul · Ascentage Investigative Ste #8208, Uijeongbu-si
Registry updated 2026-09-15
NCT03459534
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Trial Treatment · Phase 3 · Il-Yang Pharm. Co., Ltd.
Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si
Registry updated 2026-09-03
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Busan · Jeollanam · Seoul · Uijeongbu-si
Registry updated 2026-07-06
NCT05943522
Asciminib RMP Study
Research · Novartis Pharmaceuticals
Anyang-si · Bucheon-si · Gyeonggi-do · Incheon · Jeollanam · Pusan · Seoul · Suwon · Taegu · Uijeongbu-si · Wŏnju
Registry updated 2026-04-20
NCT06368414
A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
Trial Treatment · Phase 2 · Korean Society of Hematology
Gachon University Gil Medical Center, Incheon
Registry updated 2026-04-02
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Trial Treatment · Phase 1 · Enliven Therapeutics
Keimyung University Dongsan Hospital, Daegu · Uijeongbu Eulji Medical Center, Gyeonggi-do · Chonnam National University Hwasun Hospital, Hwasun · Chonbuk National University Hospital, Jeonju · Samsung Medical Center, Seoul
Registry updated 2026-04-01
NCT03850574
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Trial Treatment · Phase 1/2 · Aptose Biosciences Inc.
Kyungpook National University Hospital, Daegu · Pusan National University Hospital, Pusan · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul
Registry updated 2025-08-26

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error